EC Number   |
Title |
Organism |
|---|
   3.4.21.B12 | Clinical significance of kallikrein-related peptidase-4 in oral cancer |
Homo sapiens |
| 3.4.21.B12 | Direct evidence that KLK4 is a hydroxyapatite-binding protein |
Homo sapiens |
| 3.4.21.B12 | KLK4 is synchronically expressed to CTSC in ameloblasts during amelogenesis molars |
Mus musculus |
| 3.4.21.B12 | Potent, selective, and cell-penetrating inhibitors of kallikrein-related peptidase 4 based on the cyclic peptide MCoTI-II |
Homo sapiens |
| 3.4.21.B12 | Properties of the 4-kallikrein panel outside the diagnostic gray zone meta-analysis of patients with positive digital rectal examination or prostate specific antigen 10 ng/ml and above |
Homo sapiens |
| 3.4.21.B12 | Prostate cancer-associated kallikrein-related peptidase 4 activates matrix metalloproteinase-1 and thrombospondin-1 |
Homo sapiens |
| 3.4.21.B12 | Tissue kallikrein-related peptidase 4 (KLK4), a novel biomarker in triple-negative breast cancer |
Homo sapiens |
| 3.4.21.B12 | Characterization of hK4 (prostase), a prostate-specific serine protease: activation of the precursor of prostate specific antigen (pro-PSA) and single-chain urokinase-type plasminogen activator and degradation of prostatic acid phosphatase |
Homo sapiens |
| 3.4.21.B12 | Characterization of the mouse and human PRSS17 genes, their relationship to other serine proteases, and the expression of PRSS17 in developing mouse incisors |
Mus musculus |
| 3.4.21.B12 | Characterization of the mouse and human PRSS17 genes, their relationship to other serine proteases, and the expression of PRSS17 in developing mouse incisors |
Homo sapiens |
